about
Has the time for first-line treatment with second generation tyrosine kinase inhibitors in patients with chronic myelogenous leukemia already come? Systematic review and meta-analysis.Intelligent Techniques Using Molecular Data Analysis in Leukaemia: An Opportunity for Personalized Medicine Support System.
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Clinical trials in chronic myeloid leukemia.
@en
Clinical trials in chronic myeloid leukemia.
@nl
type
label
Clinical trials in chronic myeloid leukemia.
@en
Clinical trials in chronic myeloid leukemia.
@nl
prefLabel
Clinical trials in chronic myeloid leukemia.
@en
Clinical trials in chronic myeloid leukemia.
@nl
P2860
P1476
Clinical trials in chronic myeloid leukemia.
@en
P2093
Markus Pfirrmann
Susanne Saussele
P2860
P2888
P304
P356
10.1007/S11899-012-0118-1
P577
2012-06-01T00:00:00Z